Business · 30/05/2014

FDA Announces Final Guidance on Expedited Drug Development Programs for Serious Conditions

The US Food and Drug Administration (FDA) has released a final guidance document outlining its policies and procedures for expedited drug development and review programs, aimed at addressing unmet medical needs for serious or life-threatening conditions.